Results
No | Partial response | Complete response | Local control | Metastasis melanoma | Death | Cryotherapy symblepharon | Pretreatment vision | Most recent vision | Side effects | Follow up (months) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Short term | Long term | ||||||||||||||||||||
1 | adjuvant | adjuvant | yes | none | No | none | 20 | 20 | KC | None | 46 | ||||||||||
2 | yes | no | no | yes | No | none | 25 | prosthesis | KC | None | 42 | ||||||||||
3 | adjuvant | adjuvant | yes | none | No | yes | 40 | 30 | KC | None | 40 | ||||||||||
4 | adjuvant | adjuvant | yes | none | No | none | 20 | 20 | KC | None | 37 | ||||||||||
5 | adjuvant | adjuvant | yes | none | No | none | 25 | 25 | KC | None | 32 | ||||||||||
6 | no | yes | yes | none | CLL | no cryotherapy | 30 | 30 | KC | Corneal haze | 26 | ||||||||||
7 | adjuvant | adjuvant | yes | none | No | none | 20 | 20 | KC | None | 24 | ||||||||||
8 | adjuvant | adjuvant | yes | none | No | none | 20 | 20 | KC | None | 21 | ||||||||||
9 | no | yes | no | none | No | no cryotherapy | 20 | 20 | KC | None | 12 | ||||||||||
10 | yes | no | yes | none | No | no cryotherapy | 32 | 200† | KC | None‡ | 6 | ||||||||||
Mean | 29 |
↵Subconjunctival recurrence; †cataract progression;‡cataract not thought due to MMC. KC = keratoconjunctivitis.